IRVINE, Calif., Jan. 26, 2021 /PRNewswire/ -- Today, Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of
CoolSculpting® Elite, its next generation fat reduction
system with applicators designed to complement the body's natural
curves. CoolSculpting® Elite harnesses proven
CoolSculpting® technology to target, freeze, and
eliminate treated fat cells. CoolSculpting® Elite is FDA
cleared to treat visible fat bulges in nine areas of the body
including the thigh, abdomen, and flank, along with bra fat, back
fat, underneath the buttocks (also known as banana roll), upper
arm, and the submental and submandibular areas.
"The number one aesthetic concern for consumers is excess body
fat1. CoolSculpting® has been an
industry-leader, creating the market for non-invasive fat reduction
over 10 years ago. Now CoolSculpting® Elite
builds on that heritage with a completely re-invented
next-generation technology that delivers results," says
Carrie Strom, Senior Vice President,
AbbVie, and President, Global Allergan Aesthetics. "We understand
the challenges of today's world and as people prepare to go from
being online to spending more time in person,
CoolSculpting® Elite can help them address
their bothersome fat."
CoolSculpting® Elite will launch with a new
applicator collection, which includes seven different shapes and
sizes. The innovative new C-shaped applicators are designed to
complement the body's natural curves for improved fit and comfort
during initial tissue draw and features up to an 18% larger cooling
area as compared to the previous generation CoolSculpting
applicators. The clinical significance of these data has not been
established.
"CoolSculpting® is a critical part of my business and
a device I've relied on to help my patients achieve their desired
outcome of reducing stubborn fat." said Dr. Sabrina Fabi, Board Certified Dermatologist and
Associate Research Director at Cosmetic Laser Surgery in
San Diego. "The dual applicators
allow us to treat two areas at the same time, safely freezing twice
the fat compared to using a single CoolSculpting applicator, which
helps us save on time. With the Elite applicator collection we are
able to treat a wide range of body areas and personalize each
patient's treatment plan."
Allergan Aesthetics™ is now taking orders for the
CoolSculpting® Elite device, and the first units will
ship in Q1 2021. For more information and to find a provider near
you, visit http://find.coolsculpting.com/find-a-center/.
- American Society for Dermatologic Surgery (ASDS) consumer
survey on cosmetic dermatologic procedures 2018 available
at https://www.asds.net/skin-experts/news-room/press-releases/asds-survey-dermatologists-no-1-influencer-for-cosmetic-procedures-and-skin-care-decisions.
N= 3,525 total study population. Data were obtained through a blind
online survey conducted from May 1 to June
20 through the web-based Survata service.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop,
manufacture, and market a portfolio of leading aesthetics brands
and products. Our aesthetics portfolio includes facial injectables,
body contouring, plastics, skin care, and more. Our goal is to
consistently provide our customers with innovation, education,
exceptional service, and a commitment to excellence, all with a
personal touch. For more information, visit
www.AllerganAesthetics.com.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, women's health and
gastroenterology, in addition to products and services across its
Allergan Aesthetics portfolio. For more information about AbbVie,
please visit us at www.abbvie.com. Follow @abbvie on Twitter,
Facebook, Instagram, YouTube and LinkedIn.
COOLSCULPTING® AND COOLSCULPTING® ELITE
IMPORTANT INFORMATION
Indications
CoolSculpting® and
CoolSculpting® Elite are FDA-cleared for the
treatment of visible fat bulges in the thigh, abdomen, and flank,
along with bra fat, back fat, underneath the buttocks (also known
as banana roll), and upper arm in patients with a Body Mass Index
(BMI) of ≤ 30 and in submental and submandibular areas in patients
with a BMI of ≤ 46.2. It is also FDA-cleared to affect the
appearance of lax tissue with submental area treatments.
Important Safety Information
CoolSculpting®
and CoolSculpting® Elite are contraindicated in
patients with cryoglobulinemia, cold agglutinin disease, or
paroxysmal cold hemoglobinuria.
Ask your patient about any medical conditions including recent
surgery, pre-existing hernia, and any known sensitivities or
allergies.
During the procedure patients may experience sensations of
pulling, tugging, mild pinching, intense cold, tingling, stinging,
aching, and cramping at the treatment site. These sensations
subside as the area becomes numb. Following the procedure, typical
side effects include temporary redness, swelling, blanching,
bruising, firmness, tingling, stinging, tenderness, cramping,
aching, itching, or skin sensitivity, and sensation of fullness in
the back of the throat after submental or submandibular area
treatment.
Rare side effects may also occur. Paradoxical hyperplasia
(visibly enlarged tissue volume in the treated area) may develop 2
to 5 months after treatment and requires surgical intervention for
correction.
As with any medical procedure, a consultation should be done by
a licensed healthcare professional to determine if the patient is a
candidate for treatment. For a complete list of Contraindications,
Warnings, Precautions, and Potential Side Effects, consult the
CoolSculpting® System User Manual and the
CoolSculpting® Elite System User Manual. Treatment
applications that deviate from the guidelines are not
recommended.
COOLSCULPTING®, COOLSCULPTING® ELITE, and the
Snowflake Design are trademarks of Zeltiq Aesthetics, Inc., an
AbbVie Company. © 2020 AbbVie. All rights reserved.
For more information, please visit CoolSculpting.com. To report
an adverse reaction, please call Allergan at 1-800-433-8871.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/coolsculpting-by-allergan-aesthetics-expands-body-contouring-portfolio-with-coolsculpting-elite-301214607.html
SOURCE AbbVie